Discover
PTCT
PTC Therapeutics, Inc.
65.37
2 x 47.88
2 x 84.10
bid
ask
-
2.63
3.87%
2 @ 04:00 PM
65.37 +0.00 (0.00%)
| Ytd | -13.94% | |
| 1y | 3.96% |
65.18
day range
68.00
57.74
52 week range
90.87
| Open | 68.00 | Prev Close | 68.00 | Low | 65.18 | High | 68.00 | Mkt Cap | 5.46B |
| Vol | 3.86M | Avg Vol | 1.47M | EPS | -0.67 | P/E | N/A | Forward P/E | 24.42 |
| Beta | 0.55 | Short Ratio | 9.41 | Inst. Own | 122.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 72.58 | 200-d Avg | 72.76 | 1yr Est | 101.29 |
PTCT News
seekingalpha.com
PTC Therapeutics, Inc. (PTCT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tr
PTC Therapeutics, Inc. (PTCT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tr
defenseworld.net
Amundi Raises Holdings in PTC Therapeutics, Inc. $PTCT
Amundi grew its stake in shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) by 171.7% during the undefi
defenseworld.net
California State Teachers Retirement System Has $543.82 Million Stock Position in PTC Therapeutics,
California State Teachers Retirement System raised its stake in shares of PTC Therapeutics, Inc. (NA
benzinga.com
PTC Therapeutics To Present New Sephience Data At The 2026 Society For The Study Of Inborn Errors Of
The presentations include new data from clinical trials and real-world evidence which reinforce the